Sign In


​The main focus of the group is the prevention of human diseases such as diabetes, endocrine deficiencies, immunological diseases and cancer through the identification of early diagnostic and prognostic biomarkers using next generation sequencing multi-platform OMICs technologies (genomic, transcriptomics and epigenetics) coupled with novel bioinformatics algorithms and/or tools developed by the group.